Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
37
RMD Quote, Financials, Valuation and Earnings
Last price:
$244.78
Seasonality move
:
3.96%
Day range:
$243.13 - $247.45
52-week range:
$199.92 - $293.81
Dividend yield:
0.92%
P/E ratio:
25.03x
P/S ratio:
6.85x
P/B ratio:
5.83x
Volume:
718.5K
Avg. volume:
1M
1-year change:
5.81%
Market cap:
$35.7B
Revenue:
$5.1B
EPS (TTM):
$9.77
ResMed, Inc. Number of Institutional Trades
ResMed, Inc. Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$3.7B
(Last 6 Months)
Current Institutional Ownership Percentage
93.55%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$5.1B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ResMed, Inc. Institutional Ownership
-
What Percentage Of RMD Is Owned by Institutions?
93.55% of RMD is owned by institutions.
-
How Many Institutions Own RMD Shares?
ResMed, Inc. stock is owned by 1,801 institutional shareholders at this time.
-
Have Institutions Been Buying RMD Stock?
Yes, institutions have bought 0 shares of RMD in the last quarter.
-
Have Institutions Been Selling RMD Stock?
Yes, institutions have sold 0 shares of RMD over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
